Long-term follow-up confirms patients with high-risk breast lesions can be successfully managed at a multidisciplinary conferences长期随访证实,高风险乳腺病变患者可以通过多学科会议成功管理。Breast Cancer Research and TreatmentIF32025-09-260PRE
Management of Papilloma Lesions from a Prospective Multidisciplinary Conference with Long-term Follow-upLABORATORY INVESTIGATIONIF4.22025-03-010PRE
Certain Patients with High-risk Breast Lesions Can Be Safely Followed, Experiences from A Prospective Multidisciplinary Conference with Long-term Follow-upLABORATORY INVESTIGATIONIF4.22025-03-010PRE
The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic targetCELL BIOLOGY INTERNATIONALIF3.12022-10-063PRE
Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institutionBREAST CANCER RESEARCH AND TREATMENTIF32020-10-1720PREAI
Patients with benign papilloma diagnosed on core biopsies and concordant pathology-radiology findings can be followed: experiences from multi-specialty high-risk breast lesion conferences in an academic centerBREAST CANCER RESEARCH AND TREATMENTIF32020-07-237PREAI
Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinomaBREAST CANCER RESEARCH AND TREATMENTIF32020-01-3020OAAI
The endogenous oxindole isatin induces apoptosis of MCF-7 breast cancer cells through a mitochondrial pathwayONCOLOGY REPORTSIF3.92014-08-2020OAAI
Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancerJOURNAL OF BIOMEDICAL SCIENCEIF12.12013-07-3024OAAI
Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relativesBREAST CANCER RESEARCH AND TREATMENTIF32008-05-1632PREAI
The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relativesBREAST CANCER RESEARCH AND TREATMENTIF32008-04-3076PREAI